Minlan Yang Selected Research

claudin 6

6/2018	CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
11/2017	CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
6/2016	CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells.
1/2016	DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
11/2013	Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.
8/2013	The distinct expression patterns of claudin-2, -6, and -11 between human gastric neoplasms and adjacent non-neoplastic tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minlan Yang Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 08/2013
7	Breast Neoplasms (Breast Cancer) 06/2018 - 03/2014
3	Squamous Cell Carcinoma of Head and Neck 07/2021 - 01/2021
2	Obstructive Sleep Apnea 01/2022 - 01/2021
2	Healthcare-Associated Pneumonia 01/2021 - 08/2019
2	Carcinogenesis 01/2021 - 01/2021
1	Nasopharyngeal Carcinoma 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Obesity 01/2022
1	Bacteremia 11/2021
1	Pneumococcal Pneumonia 11/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Labyrinth Diseases 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Headache (Headaches) 08/2020
1	Noise-Induced Hearing Loss (Acoustic Trauma) 08/2020
1	Osteoporosis 08/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2019
1	Infections 08/2019
1	Triple Negative Breast Neoplasms 06/2018
1	Carcinoma (Carcinomatosis) 11/2013
1	Neoplasm Metastasis (Metastasis) 11/2013
1	Ovarian Neoplasms (Ovarian Cancer) 11/2013
1	Adenoma (Adenomas) 11/2013
1	Stomach Neoplasms (Stomach Cancer) 08/2013

Drug/Important Bio-Agent (IBA)

6	claudin 6IBA 06/2018 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2013
4	ClaudinsIBA 06/2018 - 08/2013
4	Tight Junction ProteinsIBA 06/2018 - 08/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 08/2019
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 03/2014
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2021
1	CarbonIBA 01/2022
1	IronIBA 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	MacrolidesIBA 11/2021
1	Penicillins (Penicillin)FDA Link 11/2021
1	tazobactam drug combination ceftolozaneIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SteroidsIBA 08/2020
1	Metal-Organic FrameworksIBA 08/2020
1	Hormones (Hormone)IBA 08/2020
1	Antimicrobial PeptidesIBA 08/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Neuropeptide YIBA 01/2018
1	Type C PhospholipasesIBA 01/2018
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 08/2017
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 06/2016
1	JNK Mitogen-Activated Protein KinasesIBA 06/2016
1	Green Fluorescent ProteinsIBA 03/2014
1	Transcription Factors (Transcription Factor)IBA 03/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	Matrix Metalloproteinases (MMPs)IBA 11/2013
1	OccludinIBA 11/2013
1	StreptavidinIBA 08/2013
1	Claudin-2IBA 08/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 08/2019
2	Immunotherapy 01/2021 - 01/2021
1	Complementary Therapies (Alternative Medicine) 11/2021
1	Therapeutics 01/2021
1	Bariatric Surgery 01/2021
1	Molecular Targeted Therapy 01/2021
1	Length of Stay 08/2019